have demonstrated that elevated MYBL2 expression correlates with metastasis, poorer disease-free survival, and shorter overall survival in breast cancer, highlighting how increased MYBL2 expression contributes to the disease’s enhanced invasiveness (22, 23). This evidence concerns the gene MYBL2 and breast cancer.